Display options
Cite
van Roekel EH, Loftfield E, Kelly RS, et al. Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists. Metabolomics. 2019;15(1):9doi: 10.1007/s11306-018-1468-z.
van Roekel, E. H., Loftfield, E., Kelly, R. S., Zeleznik, O. A., & Zanetti, K. A. (2019). Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists. Metabolomics : Official journal of the Metabolomic Society, 15(1), 9. https://doi.org/10.1007/s11306-018-1468-z
van Roekel, Eline H, et al. "Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists." Metabolomics : Official journal of the Metabolomic Society vol. 15,1 (2019): 9. doi: https://doi.org/10.1007/s11306-018-1468-z
van Roekel EH, Loftfield E, Kelly RS, Zeleznik OA, Zanetti KA. Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists. Metabolomics. 2019 Jan 07;15(1):9. doi: 10.1007/s11306-018-1468-z. PMID: 30830482; PMCID: PMC7844759.
Copy Download .nbib Format: NLM
Share it on

Metabolomics. 2019 Jan 07;15(1):9. doi: 10.1007/s11306-018-1468-z.

Metabolomics in epidemiologic research: challenges and opportunities for early-career epidemiologists.

Metabolomics : Official journal of the Metabolomic Society

Eline H van Roekel, Erikka Loftfield, Rachel S Kelly, Oana A Zeleznik, Krista A Zanetti

Affiliations

  1. Department of Epidemiology, GROW School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, Netherlands. [email protected].
  2. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  3. Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  4. Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, USA.

PMID: 30830482 PMCID: PMC7844759 DOI: 10.1007/s11306-018-1468-z

Abstract

BACKGROUND: The application of metabolomics to epidemiologic studies is increasing.

AIM OF REVIEW: Here, we describe the challenges and opportunities facing early-career epidemiologists aiming to apply metabolomics to their research.

KEY SCIENTIFIC CONCEPTS OF REVIEW: Many challenges inherent to metabolomics may provide early-career epidemiologists with the opportunity to play a pivotal role in answering critical methodological questions and moving the field forward. Although generating large-scale high-quality metabolomics data can be challenging, data can be accessed through public databases, collaboration with senior researchers or participation within interest groups. Such efforts may also assist with obtaining funding, provide knowledge on training resources, and help early-career epidemiologists to publish in the field of metabolomics.

Keywords: Challenges; Early-career scientists; Epidemiology; Metabolomics; Opportunities

References

  1. Metabolomics. 2018;14(6):72 - PubMed
  2. Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1483-1490 - PubMed
  3. Am J Clin Nutr. 2015 May;101(5):1000-11 - PubMed
  4. J Proteome Res. 2018 Jan 5;17(1):337-347 - PubMed
  5. Am J Clin Nutr. 2017 Aug;106(2):637-649 - PubMed
  6. Adv Nutr. 2014 Nov 14;5(6):785-8 - PubMed
  7. Metabolomics. 2014 Apr 1;10(2):259-269 - PubMed
  8. Am J Epidemiol. 2013 Aug 15;178(4):534-42 - PubMed
  9. Mutagenesis. 2015 Nov;30(6):743-53 - PubMed
  10. Nature. 2008 May 15;453(7193):396-400 - PubMed
  11. Int J Cancer. 2015 Feb 1;136(3):516-26 - PubMed
  12. PLoS One. 2014 May 01;9(5):e95749 - PubMed
  13. Metabolomics. 2007 Sep;3(3):211-221 - PubMed
  14. Circ Cardiovasc Genet. 2017 Apr;10(2): - PubMed
  15. Am J Clin Nutr. 2017 Oct;106(4):1131-1141 - PubMed
  16. Circulation. 2015 Mar 3;131(9):774-85 - PubMed
  17. BMC Med. 2015 Sep 23;13:242 - PubMed
  18. Clin Chem. 2013 Nov;59(11):1657-67 - PubMed
  19. Cancer. 2014 Oct 1;120(19):3049-57 - PubMed
  20. Diabetes. 2013 Feb;62(2):639-48 - PubMed
  21. Mol Syst Biol. 2012;8:615 - PubMed
  22. Cancer Res. 2014 Jun 15;74(12):3259-70 - PubMed
  23. Hypertension. 2013 Aug;62(2):398-403 - PubMed
  24. PLoS One. 2016 Feb 10;11(2):e0148361 - PubMed
  25. Diabetologia. 2018 Jul;61(7):1581-1591 - PubMed
  26. Diabetes. 2013 Dec;62(12):4270-6 - PubMed
  27. Int J Cancer. 2015 Nov 1;137(9):2124-32 - PubMed
  28. J Clin Epidemiol. 2010 Sep;63(9):970-9 - PubMed
  29. PLoS One. 2012;7(7):e40459 - PubMed
  30. Nutrients. 2018 Feb 10;10(2): - PubMed
  31. Br J Cancer. 2016 Oct 25;115(9):1087-1095 - PubMed
  32. Am J Epidemiol. 2014 Jul 15;180(2):129-39 - PubMed
  33. Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2182-201 - PubMed
  34. Clin Infect Dis. 2015 Jun 15;60(12):1767-75 - PubMed
  35. Nat Med. 2011 Apr;17(4):448-53 - PubMed
  36. J Natl Cancer Inst. 2018 Jun 1;110(6):588-597 - PubMed
  37. J Proteome Res. 2017 Sep 1;16(9):3137-3146 - PubMed
  38. Metabolomics. 2009 Dec;5(4):435-458 - PubMed
  39. Genome Med. 2016 Mar 31;8(1):34 - PubMed
  40. Eur J Epidemiol. 2018 Jan;33(1):55-66 - PubMed
  41. Electrophoresis. 2017 Sep;38(18):2232-2241 - PubMed
  42. Clin Chem. 2018 Aug;64(8):1158-1182 - PubMed
  43. Int J Cancer. 2016 Jan 15;138(2):348-60 - PubMed
  44. PLoS Negl Trop Dis. 2016 Apr 07;10(4):e0004607 - PubMed
  45. J Pharm Biomed Anal. 2018 Jan 5;147:149-173 - PubMed

MeSH terms

Publication Types

Grant support